Fatty acid metabolism in phorbol ester-differentiating human leukemia cells

Area of Science:

• Cell Biology
• Biochemistry
• Molecular Pharmacology

Background:

• Human promyelocytic leukemia (HL-60) cells differentiate upon exposure to 12-O-tetradecanoylphorbol-13-acetate (TPA).
• TPA primarily targets cell membranes, suggesting potential impacts on lipid metabolism.

Purpose of the Study:

• To investigate the influence of phorbol ester (TPA) exposure on fatty acid metabolism in HL-60 cells.
• To determine if observed metabolic changes are due to TPA directly or cellular differentiation.

Main Methods:

• Incubation of HL-60 cells with labeled fatty acids.
• Analysis of lipid radioactivity distribution (phospholipids vs. triacylglycerols).
• Quantification of cellular lipid content and specific activity.
• Measurement of fatty acid conversion and composition.

Main Results:

• TPA treatment significantly increased triacylglycerol content (3.2-fold) and shifted lipid radioactivity towards triacylglycerols.
• Cellular phospholipid content increased moderately (approx. 50%) at higher TPA concentrations.
• TPA-treated cells showed reduced conversion of stearic acid to monoenoic products and decreased unsaturation in triacylglycerol acyl groups.

Conclusions:

• TPA profoundly impacts fatty acid metabolism in HL-60 cells, primarily affecting triacylglycerol synthesis and fatty acid unsaturation.
• Observed metabolic modifications are likely a consequence of TPA-induced cellular differentiation rather than a direct short-term effect of TPA.